Researchers discover primary sensor that detects stomach viruses

Jul 18, 2008

Scientists at Washington University School of Medicine in St. Louis have identified the primary immune sensor that detects the presence of stomach viruses in the body. They show that the sensor – a protein called MDA-5 – triggers an immune response that revs up the body's defenses to fight off the infection. This knowledge may help develop a treatment that prevents or reduces infection, the researchers suggest in their study, published July 18th in the open-access journal PLoS Pathogens.

The stomach flu is technically not the flu at all: the flu virus only affects the respiratory tract. The stomach flu is known scientifically as a norovirus. Norovirus outbreaks are common in locations where people live close together, such as cruise ships, nursing homes, military bases and schools. Antibiotics are ineffective, because they fight bacteria, not viruses. Only recently have scientists been able to grow noroviruses in the laboratory and study them.

"Our research strongly indicates that MDA-5 is the primary sensor for norovirus infection, but the body's ability to detect the virus is so important that it doesn't just rely on one sensor," says senior investigator Marco Colonna, M.D., professor of pathology and immunology. "We found that another protein sensor – TLR3 – serves as a back-up and there may be others that have not yet been discovered."

The team demonstrated their work in mice but says the same proteins are likely responsible for detecting norovirus infection in humans. MDA-5, and to a lesser extent, TLR3, respond by causing other cells to release interferon, which shuts down production of the virus and initiates a full-scale immune attack. MDA-5 and TLR3 are both intracellular proteins. The researchers suspected that these two proteins may be important in detecting noroviruses because they are known to be important in recognizing similar types of viral infections.

Lead author Stephen McCartney, a graduate student in Colonna's lab, first found that cells in the test tube that lack the MDA-5 protein don't mount an appropriate immune response against norovirus infection.

The team then investigated two groups of mice – one group was bred without the ability to produce MDA-5 and the other was bred to lack TLR3. Again, both groups of mice had a defective immune response against noroviruses. In particular, mice without MDA-5 had higher levels of norovirus in their bodies and a defect in the ability to signal other immune cells to respond. Mice that lacked TLR3 also had a decreased response to norvirus infection, the researchers noted.

Interestingly, some people have common variations of the MDA-5 gene that could make them more susceptible to norovirus infection, the researchers say. A norovirus treatment could be especially helpful to people who are more prone to the infection.

Citation: McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin IV HW, et al. (2008) MDA-5 Recognition of a Murine Norovirus. PLoS Pathog 4(7): e1000108. doi:10.1371/journal.ppat.1000108

Source: Public Library of Science

Explore further: The Ebola outbreak highlights shortcomings in disease surveillance and response – and where we can do better

Related Stories

Filmmakers look to Twitter, Facebook for stars

4 hours ago

Looking for a tattooed demon to be killed by an undercover virgin in your sex club? Well, as any good horror film producer knows, the best place to look these days is on Facebook and Twitter.

Recommended for you

Aspirin to improve leg ulcers

9 hours ago

Researchers are looking at whether aspirin can improve the healing rates of leg ulcers in older adults.

Sierra Leone marks grim Ebola anniversary

13 hours ago

On May 24 last year a pregnant woman and an older housewife staggered into Kenema hospital in eastern Sierra Leone and were diagnosed within a day as the country's first Ebola cases.

MSF fighting cholera outbreak in Tanzania refugee camps

May 24, 2015

Medical charity Medecins sans Frontieres (MSF, Doctors Without Borders) said Sunday it had launched emergency treatment centres in Tanzania, where thousands of Burundians fleeing unrest have been hit by cholera.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.